CIK 0001326190
- Non-accelerated filer
- Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 202726770
- Phone
- +1 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 4 Shares withheld for taxes President and CEO gave up 2,243 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 60 shares (option exercise)
- 4 Open-market sale Director sold 10,150 shares at $9.91 ($100,587)
- 4 Open-market sale Director sold 10,352 shares at $9.90 ($102,485)
- 4 Open-market sale Director sold 4,015 shares at $10.02 ($40,230)
- 4 Shares withheld for taxes President and CEO gave up 2,015 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 25,275 shares (option exercise)
- 4 Exercise or conversion Director acquired 16,850 shares (option exercise)
- 4 Exercise or conversion Director acquired 16,850 shares (option exercise)
- 4 Exercise or conversion Director acquired 16,850 shares (option exercise)
- 4 Exercise or conversion Director acquired 16,850 shares (option exercise)
- 4 Exercise or conversion Director acquired 16,850 shares (option exercise)
- 4 Shares withheld for taxes President & CEO gave up 2,015 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 34 · 674 filings